HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mingzhi Zhang Selected Research

pegaspargase (Oncaspar)

1/2022Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.
1/2022DDGP followed by radiotherapy vs VIPD followed by radiotherapy in newly diagnosed early NK/T-cell lymphoma.
1/2021Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T-cell lymphoma: A randomized, controlled, open-label, multicenter study.
1/2019Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.
1/2017Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.
9/2016The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.
8/2016Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149.
3/2016S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.
11/2014Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mingzhi Zhang Research Topics

Disease

79Neoplasms (Cancer)
10/2022 - 05/2009
36Lymphoma (Lymphomas)
10/2022 - 09/2011
21T-Cell Lymphoma (Lymphoma, T Cell)
10/2022 - 05/2004
20Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 04/2013
15Hypertension (High Blood Pressure)
01/2022 - 04/2011
10Inflammation (Inflammations)
06/2021 - 03/2012
9Obesity
01/2022 - 04/2014
8Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 11/2013
8Prostatic Neoplasms (Prostate Cancer)
04/2021 - 11/2015
7Neoplasm Metastasis (Metastasis)
01/2019 - 05/2009
6Carcinogenesis
09/2022 - 02/2015
6Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 11/2015
6Myopia
07/2021 - 08/2011
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 01/2016
6Refractive Errors (Refractive Error)
01/2021 - 12/2007
6Glioma (Gliomas)
12/2019 - 08/2015
5Hematologic Neoplasms (Hematological Malignancy)
10/2022 - 11/2018
5Extranodal NK-T-Cell Lymphoma
01/2022 - 11/2014
5Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021 - 03/2016
5Glaucoma
03/2020 - 02/2010
5Carcinoma (Carcinomatosis)
01/2018 - 12/2014
4Hodgkin Disease (Hodgkin's Disease)
07/2022 - 01/2017
4Cataract (Cataracts)
07/2022 - 12/2007
4Leukemia
06/2022 - 08/2015
4Ischemic Stroke
06/2022 - 06/2014
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 09/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2013
4Stroke (Strokes)
01/2022 - 07/2016
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 12/2014
4Breast Neoplasms (Breast Cancer)
01/2021 - 11/2013
4Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2015
4Ganglion Cysts (Ganglion)
05/2019 - 01/2016
4Macular Degeneration (Age-Related Maculopathy)
01/2019 - 01/2013
4Esophageal Squamous Cell Carcinoma
11/2018 - 02/2015
4Open-Angle Glaucoma (Glaucoma, Open Angle)
07/2015 - 01/2012
3Infections
01/2022 - 12/2014
3Rhinitis
07/2021 - 08/2014
3Astigmatism
07/2021 - 08/2011
3Body Weight (Weight, Body)
04/2021 - 04/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2009
15Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2012
14GemcitabineFDA Link
01/2022 - 11/2014
14Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2013
14Rituximab (Mabthera)FDA Link
10/2021 - 04/2013
13Retinaldehyde (Retinal)IBA
01/2022 - 03/2008
13Biological ProductsIBA
10/2020 - 02/2015
11Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 03/2012
10LipidsIBA
01/2021 - 04/2011
9pegaspargase (Oncaspar)FDA Link
01/2022 - 11/2014
9Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021 - 02/2007
7Chimeric Antigen ReceptorsIBA
06/2022 - 09/2015
7Prednisone (Sone)FDA LinkGeneric
01/2022 - 01/2017
7Etoposide (VP 16)FDA LinkGeneric
01/2022 - 01/2018
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 04/2011
7MicroRNAs (MicroRNA)IBA
01/2021 - 07/2011
7Messenger RNA (mRNA)IBA
10/2019 - 02/2007
7Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2012
6DNA (Deoxyribonucleic Acid)IBA
04/2022 - 08/2014
6Pharmaceutical PreparationsIBA
01/2021 - 11/2013
5Circular RNAIBA
09/2022 - 11/2019
5Natriuretic PeptidesIBA
06/2022 - 01/2020
5Thalidomide (Thalomid)FDA Link
01/2022 - 01/2017
5Monoclonal AntibodiesIBA
01/2022 - 08/2015
5Long Noncoding RNAIBA
01/2021 - 09/2017
5Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 01/2017
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2017
5LigandsIBA
08/2020 - 04/2012
5C-Reactive ProteinIBA
07/2019 - 06/2013
5Pyruvic Acid (Pyruvate)IBA
02/2017 - 10/2015
4ibrutinibIBA
01/2022 - 03/2016
4RNA (Ribonucleic Acid)IBA
01/2022 - 12/2015
4FurinIBA
04/2021 - 11/2019
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2021 - 11/2015
4Insulin (Novolin)FDA Link
01/2021 - 04/2011
4AlbuminsIBA
10/2020 - 01/2018
4AntigensIBA
08/2020 - 09/2015
4Oxidoreductases (Dehydrogenase)IBA
02/2017 - 10/2015
4Small Interfering RNA (siRNA)IBA
02/2015 - 01/2012
3Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 01/2020
3Asparaginase (Elspar)FDA Link
01/2022 - 01/2017
3N-propionylprocainamideIBA
01/2022 - 01/2020
3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
01/2022 - 01/2020
3Uric Acid (Urate)IBA
01/2022 - 01/2020
3Atrial Natriuretic Factor (ANF)IBA
01/2022 - 01/2020
3CateninsIBA
10/2021 - 05/2009
3Transforming Growth Factors (Transforming Growth Factor)IBA
10/2021 - 09/2013
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2021 - 01/2017
3Methotrexate (Mexate)FDA LinkGeneric
06/2021 - 11/2013
3EnzymesIBA
06/2021 - 08/2016
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 01/2018
3apatinibIBA
12/2020 - 03/2018
3CytokinesIBA
08/2020 - 12/2014
3Immune Checkpoint InhibitorsIBA
01/2020 - 01/2017

Therapy/Procedure

34Therapeutics
06/2022 - 12/2010
27Drug Therapy (Chemotherapy)
01/2022 - 05/2013
10Immunotherapy
07/2022 - 09/2015
9Radiotherapy
01/2022 - 11/2013
4Eyeglasses (Spectacles)
08/2011 - 12/2008
3Intraocular Lenses (Intraocular Lens)
01/2021 - 12/2007